Compare — Georgia Financials

panel 2026-09-21Ask

Pooled trend

4 companies

Aggregate by year

GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series

Metric	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
Revenue	571,844	597,221	665,055	770,426	929,435	937,168	907,756	1,031,640
EBITDA	77,598	64,607	92,092	111,595	137,688	120,480	79,217	119,355
Net profit	44,636	53,852	51,388	55,129	111,841	88,098	41,495	88,258
Total assets	383,962	437,364	583,887	683,945	796,870	857,894	839,842	933,902
n (companies reporting)	3	3	3	4	4	4	4	4

Per-company contribution by year

XLSX

GEL, thousands

Company	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024
PSP Pharma	477,265	490,933	541,555	634,296	745,080	744,758	775,596	845,163
GM Pharmaceuticals	94,259	105,923	123,065	135,929	183,285	191,099	130,729	184,906
Sports Saiens Georgia	320	365	435	200	510	787	931	967
Alpha	—	—	—	0	560	524	500	604

Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.

Peer coverage varies by year — FY2017–FY2020 pool fewer than the 4 picked companies (see the n row). A year is never dropped because one peer is missing.

Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.